Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 5/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL471847 | 0.92 | DHFR (0.51) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| Phthalic Acid SCHEMBL28905512 | 0.91 | DHFR (0.49) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL19732910 | 0.89 | DHFR (0.46) | DHFRMGLLL3MBTL1ALDH1A1GLA | |
| SCHEMBL27669934 | 0.86 | DHFR (0.49) | DHFRMGLLL3MBTL1MAPK1 | |
| SCHEMBL20239041 | 0.85 | DHFR (0.55) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL27664394 | 0.84 | ALDH1A1 (0.42) | MGLLL3MBTL1ALDH1A1GLA | |
| SCHEMBL9770446 | 0.84 | DHFR (0.54) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL1714071 | 0.84 | DHFR (0.54) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL9105345 | 0.83 | DHFR (0.41) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 | |
| SCHEMBL29763757 | 0.82 | DHFR (0.44) | DHFRMGLLL3MBTL1MAPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3260444-A1 | SULFONIUM BORATE SALT, ACID GENERATING AGENT AND CURABLE COMPOSITION | San-Apro Ltd. (JP) | 2017-12-27 | — | — | EP | disclosed |